sabato 4 ottobre 2014

Clinical Trial Of Juno Therapeutics Cell Therapy Restarts

Earlier this month, a study of a much-watched cell therapy that genetically modifies patients’ immune cells in order to attack tumors was stopped because the treatment may have caused the deaths of two patients. The trial is now once again enrolling patients, according to Juno Therapeutics, the startup that is commercializing [...]



Clinical Trial Of Juno Therapeutics Cell Therapy Restarts

Nessun commento:

Posta un commento